Category Archives: Business and Investments

Latest From Business and Investments

Morning Consult: Right-Sized Regulations, Innovation and Investor Protection

Jim Greenwood

Today, an op-ed from BIO President and CEO Jim Greenwood appeared in Morning Consult stressing the importance of investor protection by reforming eXtensible Business Reporting Language (XBRL), which is a one-size-fits-all costly reporting requirement that can harm company growth and investor returns. Congressman Robert Hurt (R-VA) introduced a bill – the Small Company Disclosure Simplification Act (H.R. 1965) – that would provide a temporary exemption from XBRL for newly public and low-revenue companies in order Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Innovation Zone Company Snapshots: ONL Therapeutics and Lipella Pharmaceuticals

Innovation-zone-logos-150x150

Next month in Philadelphia at the BIO International Convention, BIO will be partnering with the National Institutes of Health (NIH) and the National Science foundation (NSF) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through the SBIR/STTR review process prior Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO BizLink Approaches Milestone as Convention Approaches

BIO_BizLink_logo

In less than a year’s time, BIO BizLink, BIO’s peer-rated CRO/CMO database and project management tool, has attracted nearly 1,000 companies looking to connect in the pre-clinical and clinical contract research space! In a recent survey of biotech companies, all of those that responded indicated that they were maintaining or increasing their contract service budget over the coming year. As the industry’s largest event, the 2015 BIO International Convention in Philadelphia is perfect for meeting Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

Tick Size Pilot Program: A Few Pennies Make a Big Difference

72263479

Earlier this week, the Securities and Exchange Commission (SEC) approved a tick size pilot program that will begin next year. We issued this statement, praising the SEC for finalizing this program, which could improve liquidity and enhance capital formation for emerging biotech companies. Under current SEC rules, all securities on the public market are priced in $0.01 increments known as “tick sizes.” The switch to the standard tick size of a penny was enacted in 2000 Read More >

Business and Investments, Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , ,

FOX Business: BIO CEO Jim Greenwood Discusses State of the Industry

jim-greenwood-foxbusiness

BIO President and CEO Jim Greenwood recently appeared on Fox Business Risk & Reward with Deirdre Bolton to discuss the current state of the industry. Greenwood quickly debunked the “bubble” rumor by explaining the index continues to move up year over year and it is driven by strong science that results in strong returns and that increasing sophistication among investors allows them to more accurately assess company valuations than in the past. Further, Greenwood addressed Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,